Cathepsin B is a cysteine protease found mainly in the lysosomes of normal cells but is secreted or associated with the plasma membrane of many transformed cells. It is found in all animals and other organisms and plays a key role in cellular protein metabolism. The cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class consists of cathepsins D and E. The cysteine protease class consists of cathepsins B, L, H, K, S, and O. Currently, there are no approved cathepsin inhibitors on the market, but research is ongoing to develop new cathepsin inhibitors for the treatment of various diseases such as cancer, traumatic brain injury, Ebola infection, and others. Anti-Cathespin B antibodies are majorly used for the treatment of disease conditions such as cancer, traumatic brain injury, Ebola infection, and fertility problems, and are currently under research for the treatment of SARS-CoV-2. Cathepsin B is a protease that contributes to the remodeling of the extracellular matrix and thereby promotes keratinocyte migration during wound healing.
Market Dynamics
Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global anti-cathepsin B market growth. For instance, on March 31, 2020, National Center for Biotechnology Information published an article explaining Cathepsin B (CTSB) is an abundant cysteine protease that functions in both endolysosomal compartments and extracellular regions. Many preclinical and clinical studies indicate that CTSB is involved in many human diseases. CTSB expression levels and activity are significantly correlated with disease progression and severity. Current CTSB inhibitors lack sufficient specificity and pharmacological activity. Using structure-based rational design, researchers developed and produced a humanized antibody inhibitor targeting human CTSB.
Key features of the study:
- This report provides an in-depth analysis of the global anti-cathepsin B market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global anti-cathepsin B market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc., and Abcam Plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global anti-cathepsin B market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-cathepsin B market.
- Global Anti-Cathepsin B Market, By Product Type :
- Primary Antibodies
- Proteins and Peptides
- Lysates
- Global Anti-Cathepsin B Market, By Application :
- Cancer
- Traumatic Brain Injury
- Ebola Infection
- Fertility Treatment
- Others
- Global Anti-Cathepsin B Market, By Technique :
- Immunohistochemistry
- Immunofluorescence
- Western Blotting
- ELISA
- Flow Cytometry
- Others
- Global Anti-Cathepsin B Market, By End User
- Pharmaceutical Companies
- Academic and Research Institutes
- Global Anti-Cathepsin B Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Merck KGaA
- Bio-Techne
- BioVision Inc.
- Santa Cruz Biotechnology, Inc.
- MedChemExpress
- BioCat GmbH
- ApexBio Technology
- Cayman Chemical
- Selleck Chemicals
- BOC Sciences
- AG Scientific
- Virobay Inc.
- Abcam Plc.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Technique
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- 4. Global Anti-Cathepsin B Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Anti-Cathepsin B Market, By Product Type, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Primary Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Proteins and Peptides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Lysates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- 6. Global Anti-Cathepsin B Market, By Application, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Traumatic Brain Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Ebola Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Fertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- 7. Global Anti-Cathepsin B Market, By Technique, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Immunohistochemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Immunofluorescence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Western Blotting
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- ELISA
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Flow Cytometry
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Others
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- 8. Global Anti-Cathepsin B Market, By End User, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Pharmaceutical Companies
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Academic and Research Institutes
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- 9. Global Anti-Cathepsin B Market, By Region, 2020–2032, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021–2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020–2032, (US$ Million)
- North Africa
- Central Africa
- South Africa
- 10. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Techne
- BioVision Inc
- Santa Cruz Biotechnology, Inc
- MedChemExpress
- BioCat GmbH
- ApexBio Technology
- Cayman Chemical
- Selleck Chemicals
- BOC Sciences
- AG Scientific
- Virobay Inc
- Abcam Plc
- 11. Section
- Research Methodology
- About Us
- *Browse 40 market data tables and 48 figures on “Global Anti-Cathepsin B Market”- Global forecast to 2032
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook